Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm, Open-label, Multicenter, Phase II Study of BAY88-8223 in the Treatment of Japanese Patients With Symptomatic Castration-resistant Prostate Cancer (CRPC) With Bone Metastases

NCT01929655 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01929655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01929655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm, Open-label, Multicenter, Phase II Study of BAY88-8223 in the Treatment of Japanese Patients With Symptomatic Castration-resistant Prostate Cancer (CRPC) With Bone Metastases
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2013
Completion date
May 16, 2017
Enrollment
49 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic neoplasms